Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Brentuximab Vedotin × Clear all

Sponsor

Conditions

Hodgkin Disease 24 Lymphoma 14 Lymphoma, Large-Cell, Anaplastic 12 Hematologic Diseases 10 Recurrence 8 Lymphoma, T-Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphatic Diseases 3 Leukemia 3 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Immunoproliferative Disorders 2 Immunoblastic Lymphadenopathy 2 Immune System Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nonseminomatous germ cell tumor 1 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡